Joshua Freedman
Corporate Officer/Principal bei University of California, Los Angeles
Aktive Positionen von Joshua Freedman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | - | - |
Karriereverlauf von Joshua Freedman
Ehemalige bekannte Positionen von Joshua Freedman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
American Psychiatric Association
 American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services The American Psychiatric Association is the largest scientific and professional organization of psychiatrists. The private company is based in Arlington, VA and has subsidiaries in the United States. The company works together to ensure humane care and effective treatment for all individuals with mental illness, including substance use disorders. Marketa Wills has been the CEO of the company since 2024. | Corporate Officer/Principal | - | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Joshua Freedman
| Yale University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
American Psychiatric Association
American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services The American Psychiatric Association is the largest scientific and professional organization of psychiatrists. The private company is based in Arlington, VA and has subsidiaries in the United States. The company works together to ensure humane care and effective treatment for all individuals with mental illness, including substance use disorders. Marketa Wills has been the CEO of the company since 2024. | Commercial Services |
- Börse
- Insiders
- Joshua Freedman
- Erfahrung
